Evidence map›Paper›PMID 30222252›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2018

Investigating Subcellular Compartment Targeting Effect of Porous Coordination Cages for Enhancing Cancer Nanotherapy.

Yu Fang, Xizhen Lian, Yanyan Huang, Guo Fu, Zhifeng Xiao, Qi Wang, Beiyan Nan, Jean-Philippe Pellois, Hong-Cai Zhou

Open access · greenAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yu FangDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0001-6911-4047
Xizhen LianDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.
Yanyan HuangBeijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
Guo FuDepartment of Biology, Texas A&M University, College Station, TX, 77843, USA.
Zhifeng XiaoDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.
Qi WangDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.
Beiyan NanDepartment of Biology, Texas A&M University, College Station, TX, 77843, USA.
Jean-Philippe PelloisDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Hong-Cai ZhouDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-9029-3788
Texas A&M University · USChinese Academy of Sciences · CN

Funding

Mechanisms and optimization of endosomal escape for delivery applicationsR01GM110137 · NIGMS · TEXAS A&M AGRILIFE RESEARCH · PI PELLOIS, JEAN-PHILIPPE · 2015 to 2022
$2.3M
NIGMS NIH HHS R01 GM110137
6 · The paper itself

Abstract

Understanding the key factors for successful subcellular compartment targeting for cargo delivery systems is of great interest in a variety of fields such as bionanotechnology, cell biology, and nanotherapies. However, the fundamental basis for intracellular transportation with these systems has thus far rarely been discussed. As a cargo vector, porous coordination cages (PCCs) have great potential for use in cancer nanotherapy and to elucidate fundamental insight regarding subcellular compartment targeting. Herein, it is shown that the transportation of PCC cargo vectors though various subcellular barriers of the mammalian cell can be manipulated by tuning the vector's electronic property and surface affinity. It is found that the PCCs become selectively aggregated at the cell membrane, the cytoplasm, or the nucleus, respectively. When a DNA topoisomerase inhibitor is delivered into the nucleus by a neutral and lipophilic PCC, the anticancer efficacy is dramatically improved. The findings shed light to tune the interactions at the "bio-nano" interface. This study provides a key strategy for future work in targeting specific cell organelles for cell imaging, cargo delivery, and therapy. This research also offers key insight into the engineering of nanoscopic materials for furnishing cell organelle-specificity.

Indexed as

AnimalsBiotechnologyCell MembraneCell NucleusCytoplasmDrug Delivery SystemsHumansNanoparticlesNeoplasmsPorosityTopoisomerase InhibitorsTopoisomerase Inhibitorscancer therapycell compartment targetingcoordination cagecytotoxicitysubcellular distribution

Identifiers

PMID30222252
PMCPMC6563816
OpenAlexW2891646580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.